Abstract

This paper reviews the tools available to assess outcomes of treatment in irritable bowel syndrome, especially the effect on pain. It critically considers their development, relevance and reliability. Its conclusion is that there are few tools which meet the criteria necessary to place confidence in their validity as appropriate measures of patient outcomes.